DAX24.340 +0,2%Est505.746 -0,1%MSCI World4.343 -0,1%Top 10 Crypto10,94 -5,7%Nas23.593 -0,1%Bitcoin74.459 -0,2%Euro1,1776 ±0,0%Öl60,64 -2,6%Gold4.533 +1,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Novo Nordisk A3EU6F Rheinmetall 703000 DroneShield A2DMAA Allianz 840400 Tesla A1CX3T Nike 866993 Amazon 906866 BYD A0M4W9 Bayer BAY001 Lufthansa 823212 Deutsche Telekom 555750 D-Wave Quantum A3DSV9 Alphabet A (ex Google) A14Y6F Microsoft 870747
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt vor Weihnachten etwas höher -- Alphabet kauft Intersect -- Novo Nordisk, D-Wave, Lufthansa, Palantir, TUI, Microsoft, Bitcoin, Gold im Fokus
Top News
finanzen.net ZERO XMAS-Aktion: Jetzt Neukundenbonus und bis zu 300 Euro Prämie sichern finanzen.net ZERO XMAS-Aktion: Jetzt Neukundenbonus und bis zu 300 Euro Prämie sichern
Wie funktionieren synthetische ETFs? Vorteile und Risiken Wie funktionieren synthetische ETFs? Vorteile und Risiken
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Biotalys NV Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
3,41 EUR -0,13 EUR -3,67 %
BMN
3,40 EUR -0,12 EUR -3,41 %
EBR
Biotalys NV jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.128,11 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3CS50

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINBE0974386188

Biotalys NV Aktien News

DatumMeistgelesen
GlobeNewswireBiotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
GlobeNewswireBiotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer
GlobeNewswireBiotalys and AgroFresh Partner to Protect Fresh Produce
Wer­bungBiotalys NV-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswireResults of the Ordinary Shareholders’ Meeting
GlobeNewswireBiotalys to Appoint Toni Bucci to its Board of Directors
GlobeNewswireInvitation to the ordinary general shareholders meeting
GlobeNewswireBiotalys Reports Full-Year 2024 Financial Results and Business Highlights
GlobeNewswireBiotalys Achieves Strong Results in Field Trials with Second Biofungicide
GlobeNewswireInformation on the total number of voting rights and shares
GlobeNewswireBiotalys Provides Regulatory Review Update on EVOCA
GlobeNewswirePublication of transparency notifications
GlobeNewswireBiotalys Appoints Kamal El Mernissi as Chief Business Development Officer
GlobeNewswireBiotalys announces Closing of Private Placement
GlobeNewswireBiotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors
GlobeNewswireBiotalys Expands R&D Pipeline with New Biofungicide Program
GlobeNewswireBiotalys Granted Patents for EVOCA in Both Europe and the United States
GlobeNewswireBiotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands
GlobeNewswireBiotalys Reports Half-Year 2024 Financial Results and Business Highlights
GlobeNewswireBiotalys Named Sustainable Crop Protection Company of the Year
GlobeNewswireBiotalys Notice of Half Year 2024 Results and Business Highlights
GlobeNewswireBiotalys Starts Field Trials for Second Biofungicide
GlobeNewswireBiotalys Appoints Laura J. Meyer to Board of Directors
GlobeNewswireResults of the Ordinary and Extraordinary Shareholders’ Meeting
GlobeNewswireResults of the Special Shareholders’ Meeting
GlobeNewswireInvitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting
GlobeNewswireBiotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
GlobeNewswireInvitation to a Special Shareholders’ Meeting
GlobeNewswireBiotalys Reports Full-Year 2023 Financial Results and Business Highlights
GlobeNewswireBiotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.
GlobeNewswireInformation on the total number of voting rights and shares
GlobeNewswireBiotalys Notice of Full Year 2023 Results and Business Highlights
GlobeNewswireBiotalys Announces Results of Independent Field Trials in the U.S.
GlobeNewswireBiotalys Provides Company Update
GlobeNewswireKevin Helash commences role as Chief Executive Officer of Biotalys
GlobeNewswireBiotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase
GlobeNewswireBiotalys announces participation at upcoming scientific, industry and investor events
GlobeNewswireBiotalys Reports Half-Year 2023 Financial Results and Business Highlights
GlobeNewswireInvitation to a Special Shareholders’ Meeting
GlobeNewswirePublication of transparency notification
GlobeNewswireBiotalys announces closing of private placement

Biotalys NV News

Biotalys NV News: auf dieser Seite finden Sie alle Biotalys NV News und Nachrichten zur Biotalys NV Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Biotalys NV News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Biotalys NV News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.